Bruker AXS Announces Agreement to Acquire Elemental Analysis Company JUWE Laborgeraete GmbH
News Jan 07, 2008
Bruker AXS GmbH has announced that it has signed an agreement to acquire all of the equity of privately-held JUWE Laborgeraete GmbH from its founders. A stock purchase agreement was signed on December 21, 2007 and the transaction is expected to close in the first quarter of 2008. JUWE’s estimated 2007 revenue was approximately $3 million. Purchase price details were not disclosed.
JUWE was established in 1997 by a dedicated group of founders with many years of experience in combustion analysis of the CHNOS light elements (Carbon, Hydrogen, Nitrogen, Oxygen, and Sulfur), as a successor organization to Stroehlein AG, which closed down in 1997.
JUWE initially provided service and support for the large installed base of Stroehlein systems, and in 2004 launched a new generation of JUWE-branded combustion analysis systems. JUWE, located in Viersen, Germany, today develops, manufactures and distributes advanced combustion analysis systems for various C, H, N, O and S elemental analysis applications used in:
• metals foundries and processing;
• organic chemistry, pharma production, refineries, petrochemistry;
• aerospace, automotive and power industries;
• electrical and mechanical engineering companies;
• semiconductor technology;
• steel and building construction, bridge construction;
• raw and basic materials, ceramics; and
• materials research institutes.
After the closing of the planned acquisition of JUWE by Bruker AXS in early 2008, it is anticipated that a renamed Bruker JUWE GmbH will systematically transfer its R&D, production, service and customer applications, demonstration and training center to Kalkar, Germany.
At the combined Kalkar facility, Bruker JUWE together with spark-OES company Bruker Quantron GmbH will form a center of excellence for elemental analysis, particularly for metals analysis applications.
Commenting on the transaction, Mr. Erwin Jung, a co-founder and Managing Director of JUWE, stated: "The speed with which JUWE has been growing in the past two years has shown that we have the right team and product ideas. In order to maintain this rapid growth, we have been looking for a complementary strategic partner. In Bruker AXS we have found a company from the same industry that can positively contribute to every aspect of JUWE's business."
Mr. Bernard Kolodziej, Managing Director of Bruker AXS GmbH, commented: "We are very excited to have Karl-Josef Weifels, Erwin Jung and the very capable and experienced JUWE team join our Bruker AXS elemental analysis business. We are impressed by their advanced, yet robust, combustion analysis technology, and we believe that we can help the future Bruker JUWE accelerate its growth and global market penetration.”
Modified Form of Botox Could Replace Opioids as Treatment for Chronic PainNews
A modified form of botulinum toxin gives long-lasting pain relief in mice without adverse effects and, in time, could replace opioid drugs as a safe and effective way of treating chronic pain, according to new research.READ MORE
Key Ingredient in Diabetes Drug Modified to Improve Side EffectsNews
Improved medications for Type 2 diabetes are one step closer thanks to a new discovery reported this week. By modifying the key ingredient in current diabetes drugs, the researchers produced a compound that was effective for hyperglycemia in animal trials, yet without the most problematic side effects of current drugs.READ MORE
Tackling Cancer at Ground Zero: Designer Molecule Inhibits Protein TargetNews
A new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers. The new molecule successfully targets a protein that plays a major role in the growth of most cancers.READ MORE